Volume 134, Issue 5, Pages (May 2008)

Slides:



Advertisements
Similar presentations
L-carnitine Reduces Muscle Cramps in Patients With Cirrhosis
Advertisements

Volume 132, Issue 1, Pages (January 2007)
Volume 152, Issue 6, Pages (May 2017)
Les Lang  Gastroenterology  Volume 133, Issue 1, (July 2007)
Les Lang  Gastroenterology  Volume 133, Issue 1, (July 2007)
Volume 133, Issue 5, Pages (November 2007)
Volume 142, Issue 4, Pages (April 2012)
Volume 144, Issue 5, Pages (May 2013)
Covering the Cover Gastroenterology
Volume 140, Issue 3, Pages e3 (March 2011)
Effectiveness of Hepatitis B Treatment in Clinical Practice
Volume 153, Issue 4, Pages (October 2017)
Improved Virologic Response in Chronic Hepatitis C Genotype 4 Treated With Nitazoxanide, Peginterferon, and Ribavirin  Jean–François Rossignol, Asem Elfert,
Ira J. Fox, Stephen C. Strom  Gastroenterology 
Volume 152, Issue 6, Pages (May 2017)
Volume 140, Issue 3, Pages e10 (March 2011)
Volume 133, Issue 4, Pages (October 2007)
Volume 140, Issue 5, Pages (May 2011)
Volume 134, Issue 5, Pages (May 2008)
Volume 136, Issue 2, Pages (February 2009)
A Historical Perspective on Clinical Advances in Pancreatic Diseases
Yasuhiko Sugawara, Masatoshi Makuuchi 
Volume 155, Issue 5, Pages e2 (November 2018)
Jean-Michel Pawlotsky  Gastroenterology 
Volume 154, Issue 6, Pages (May 2018)
Nghia H. Nguyen, Vincent Nguyen, Huy N. Trinh, Brian Lin, Mindie H
Hepatitis C and Hepatocellular Carcinoma: Grist for the Mill
Volume 142, Issue 6, Pages e3 (May 2012)
Volume 144, Issue 2, Pages (February 2013)
Prevalence and Challenges of Liver Diseases in Patients With Chronic Hepatitis C Virus Infection  Ira M. Jacobson, Gary L. Davis, Hashem El–Serag, Francesco.
Daniel F. Wallace, Lesa Summerville, V. Nathan Subramaniam 
Volume 155, Issue 6, Pages (December 2018)
Volume 136, Issue 5, Pages e6 (May 2009)
Volume 142, Issue 6, Pages (May 2012)
Direct-Acting Antivirals Cure Innate Immunity in Chronic Hepatitis C
Meta-Analysis of Hepatitis C Virus Vaccine Efficacy in Chimpanzees Indicates an Importance for Structural Proteins  Harel Dahari, Stephen M. Feinstone,
Volume 132, Issue 5, Pages (May 2007)
Volume 143, Issue 3, Pages e6 (September 2012)
Rafael Esteban, Maria Buti  Gastroenterology 
Covering the Cover Gastroenterology
Volume 138, Issue 3, Pages e3 (March 2010)
Reduced Mortality Rates Following Elective Percutaneous Liver Biopsies
A View to Natural Killer Cells in Hepatitis C
Volume 133, Issue 2, Pages (August 2007)
Interleukin-28b: A Key Piece of the Hepatitis C Virus Recovery Puzzle
Volume 132, Issue 1, Pages 5-6 (January 2007)
Volume 148, Issue 3, Pages (March 2015)
Covering the Cover Gastroenterology
Genetic Factors and Hepatitis C Virus Infection
Volume 123, Issue 4, Pages (October 2002)
Volume 149, Issue 6, Pages (November 2015)
Innate immunity and HCV
Alan Bonder, MD, Nezam H. Afdhal, MD 
Volume 139, Issue 5, Pages e3 (November 2010)
Statin Therapy Improves Sustained Virologic Response Among Diabetic Patients With Chronic Hepatitis C  Gowtham A. Rao, Prashant K. Pandya  Gastroenterology 
L-carnitine Reduces Muscle Cramps in Patients With Cirrhosis
Epigastric Mass in an Infant With First Episode of Nonbilious Vomiting
Alessio Aghemo, Maria Francesca Donato  Gastroenterology 
Hepatitis C treatment in patients with kidney disease
Volume 142, Issue 6, Pages e4 (May 2012)
Volume 128, Issue 5, Pages (May 2005)
Volume 132, Issue 1, Pages (January 2007)
Meta-analysis Shows Extended Therapy Improves Response of Patients With Chronic Hepatitis C Virus Genotype 1 Infection  Harald Farnik, Christian M. Lange,
Volume 139, Issue 6, Pages e1 (December 2010)
End-Stage Liver Disease in 2008: Finally a Glass Half Full
Controversies in Liver Transplantation for Hepatitis C
The Results of Phase III Clinical Trials With Telaprevir and Boceprevir Presented at the Liver Meeting 2010: A New Standard of Care for Hepatitis C Virus.
Volume 131, Issue 5, Pages (November 2006)
Volume 156, Issue 4, Pages (March 2019)
Fasiha Kanwal, Tuyen Hoang, Timothy Chrusciel, Jennifer R
Presentation transcript:

Volume 134, Issue 5, Pages 1396-1405 (May 2008) Potential Relevance of Cytoplasmic Viral Sensors and Related Regulators Involving Innate Immunity in Antiviral Response  Yasuhiro Asahina, Namiki Izumi, Itsuko Hirayama, Tomohiro Tanaka, Mitsuaki Sato, Yutaka Yasui, Nobutoshi Komatsu, Naoki Umeda, Takanori Hosokawa, Ken Ueda, Kaoru Tsuchiya, Hiroyuki Nakanishi, Jun Itakura, Masayuki Kurosaki, Nobuyuki Enomoto, Megumi Tasaka, Naoya Sakamoto, Shozo Miyake  Gastroenterology  Volume 134, Issue 5, Pages 1396-1405 (May 2008) DOI: 10.1053/j.gastro.2008.02.019 Copyright © 2008 AGA Institute Terms and Conditions

Figure 1 Comparison of hepatic gene expression levels between chronic hepatitis C patients (n = 74) and nonviral liver disease patients (n = 5). Expression levels of RIG-I, MDA5, LGP2, Cardif, RNF125, ISG15, and USP18 are shown. Error bars indicate the standard error. Upon HCV infection, expression of these genes except Cardif was stimulated. The P values determined by Mann–Whitney U test between 2 groups were as follows: RIG-I, P .02; MDA5, P .01; LGP2, P .005; Cardif, P .7; RNF125, P .06; ISG15, P .007; USP18, P .004. Gastroenterology 2008 134, 1396-1405DOI: (10.1053/j.gastro.2008.02.019) Copyright © 2008 AGA Institute Terms and Conditions

Figure 2 Comparison of hepatic gene expression levels according to final virologic outcome. Expression levels of RIG-I, MDA5, LGP2, ISG15, USP18, Cardif, RNF125, RIG-I/Cardif ratio, and RIG-I/RNF125 ratio are shown. Open columns indicate SVR (n = 30), shaded columns indicate TR (n = 24), and solid columns indicate NVR (n = 20). Error bars indicate the standard error. The P values were analyzed by the Kruskal–Wallis test. Gastroenterology 2008 134, 1396-1405DOI: (10.1053/j.gastro.2008.02.019) Copyright © 2008 AGA Institute Terms and Conditions

Figure 3 Receiver operator characteristic (ROC) curve for prediction of nonvirologic response. ROC curves were generated to compare (A) RIG-I/Cardif ratio (solid line) and RIG-I/RNF125 ratio (shaded line); (B) RIG-I (solid line), MDA5 (shaded line), and LGP2 (dotted line); and (C) ISG15 (solid line) and USP18 (shaded line). Gastroenterology 2008 134, 1396-1405DOI: (10.1053/j.gastro.2008.02.019) Copyright © 2008 AGA Institute Terms and Conditions

Figure 4 (A) Western blot analysis. Five lanes were SVR (lanes 1–5), 4 lanes were NVR (lanes 6–9), and 3 lanes were non-HCV control (lanes 10–12). Specific bands for Cardif and β-actin are indicated by arrows. (B) Expression level of Cardif protein normalized to β-actin in the liver biopsy specimens according to ultimate treatment response. Error bars indicate the standard error. Gastroenterology 2008 134, 1396-1405DOI: (10.1053/j.gastro.2008.02.019) Copyright © 2008 AGA Institute Terms and Conditions

Figure 5 Transcriptional responses during PEG-IFN-α-2b and ribavirin therapy in PBMC (n = 14). Open columns indicate SVR (n = 7), and solid columns indicate NVR (n = 7). Error bars indicate the standard error. The P values determined by Mann–Whitney U test between 2 groups at 8 hours were as follows: RIG-I, P .3; RNF125, P .3; Cardif, P .7; ISG15, P .3; USP18, P .2. Gastroenterology 2008 134, 1396-1405DOI: (10.1053/j.gastro.2008.02.019) Copyright © 2008 AGA Institute Terms and Conditions